Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody
아랍에미리트 아부다비에서 코로나19 투석을 받은 말기 신장질환 환자의 결과; PCR에서 항체로
Research
[키워드] Abu
addition
age
antibody
Antibody Response
Antibody responses
Asymptomatic
average
average age
camostat
characteristics of patient
Cohort
combinations
Community
Comorbidities
concerning
Contact
contributed
cough
country
COVID 19
COVID-19
COVID-19 infection
COVID19
Critical care
defined
demographics
develop
diabete
diabetes
dialysis
disease
drug
End stage kidney disease
examined
family
Favipiravir
Haemodialysis
heart disease
Hydroxychloroquine
hypertension
ICU
IgG antibody
individual
infected individual
infected individuals
Infection
Ischaemic heart disease
Isolation
Kidney disease
lack
Local
Lopinavir
lower mortality
majority
male
median time
Mild
Mild disease
Mortality
Most patients
negative PCR test
outcome
overall mortality
Patient
patients
PCR
PCR positive patient
PCR positivity
PCR tests
performed
Population
positive patient
positive patients
presenting symptoms
Rapid
required
Result
Ritonavir
Screening
screening strategy
serology
source of infection
spread of COVID-19
steroid
Steroids
study period
subset
symptomatic
tested
the antibody response
Tocilizumab
Viral
viral clearance
was performed
were used
with COVID-19
[DOI] 10.1186/s12882-021-02378-y PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12882-021-02378-y PMC 바로가기 [Article Type] Research